FREM2 |
Q5SZK8
|
FRAS1 related extracellular matrix 2
|
|
3.6E-11 |
0.566 |
0.577 |
RYR2 |
Q92736
|
ryanodine receptor 2
|
Ion channel
|
1.00 |
0.539 |
0.615 |
HSPG2 |
P98160
|
heparan sulfate proteoglycan 2
|
Enzyme modulator
|
1.0E-19 |
0.438 |
0.885 |
POC1B |
Q8TC44
|
POC1 centriolar protein B
|
|
3.0E-08 |
0.705 |
0.385 |
NLRP12 |
P59046
|
NLR family pyrin domain containing 12
|
|
3.6E-28 |
0.569 |
0.846 |
PDZRN3 |
Q9UPQ7
|
PDZ domain containing ring finger 3
|
|
0.98 |
0.792 |
0.269 |
PTGIS |
Q16647
|
prostaglandin I2 synthase
|
|
1.2E-09 |
0.617 |
0.654 |
POC1B-GALNT4 |
Q8N4A0
|
POC1B-GALNT4 readthrough
|
|
0.11 |
0.890 |
0.115 |
SEZ6 |
Q53EL9
|
seizure related 6 homolog
|
|
1.7E-06 |
0.805 |
0.385 |
B3GNT6 |
Q6ZMB0
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6
|
Enzyme
|
1.1E-09 |
0.769 |
0.269 |
ARL16 |
Q0P5N6
|
ADP ribosylation factor like GTPase 16
|
|
1.7E-06 |
1.000 |
0.038 |
STAC2 |
Q6ZMT1
|
SH3 and cysteine rich domain 2
|
|
8.4E-07 |
0.839 |
0.115 |
GPR153 |
Q6NV75
|
G protein-coupled receptor 153
|
|
6.9E-07 |
0.890 |
0.115 |
MEST |
Q5EB52
|
mesoderm specific transcript
|
Enzyme
|
0.40 |
0.631 |
0.538 |
PIPOX |
Q9P0Z9
|
pipecolic acid and sarcosine oxidase
|
Enzyme
|
6.6E-12 |
0.722 |
0.346 |
RELA |
Q04206
|
RELA proto-oncogene, NF-kB subunit
|
Transcription factor
|
1.00 |
0.406 |
0.885 |
TTBK1 |
Q5TCY1
|
tau tubulin kinase 1
|
Kinase
|
1.00 |
0.792 |
0.231 |
GALNT4 |
Q8N4A0
|
polypeptide N-acetylgalactosaminyltransferase 4
|
|
0.27 |
0.736 |
0.346 |
HGS |
O14964
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
6.4E-03 |
0.597 |
0.808 |
GTF2IRD1 |
Q9UHL9
|
GTF2I repeat domain containing 1
|
|
0.90 |
0.522 |
0.769 |